Clinical Trial Update: A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating PF-07985045 alone or with other anti-cancer therapies in adults with advanced solid tumors bearing gene alterations; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• PF-07985045 (PF-07985045)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Pancreatic Ductal, Colorectal Neoplasms | Phase 1 | Status: ACTIVE_NOT_RECRUITING